Table 2 |
|||
|
Multivariate factors1 related to pharmacy as main source for syringes2 |
|||
|
Variable |
AOR |
95% CI |
p-value |
|
|
|||
|
Main drug injected during last 6 months: |
|||
|
Fentanyl |
0.62 |
0.34–1.13 |
0.120 |
|
Amphetamine |
1.13 |
0.71–1.80 |
0.609 |
|
Ever overdosed: |
|||
|
No |
1.0 |
||
|
Yes |
0.88 |
0.53–1.45 |
0.606 |
|
Sharing syringes during last 6 months: |
|||
|
No |
1.0 |
||
|
Yes |
1.42 |
0.87–2.32 |
0.159 |
|
Sharing paraphernalia during last 6 months: |
|||
|
No |
1.0 |
||
|
Yes |
1.33 |
0.76–2.34 |
0.312 |
|
Ever shared needles with someone known to be HIV positive: |
|||
|
No |
1.0 |
||
|
Yes |
0.70 |
0.40–1.23 |
0.214 |
|
Sharing needles with sexual partner during last 6 months: |
|||
|
No |
1.0 |
||
|
Yes |
1.48 |
0.65–3.36 |
0.346 |
|
Number of sexual partners during last 12 months: |
|||
|
None or one |
1.0 |
||
|
More than one |
1.88 |
1.17–3.04 |
0.009 |
|
Number of casual partners during last 6 months: |
|||
|
None |
1.0 |
||
|
One or more |
2.09 |
1.24–3.53 |
0.006 |
|
Condom use with casual partner during last 6 months: |
|||
|
Never |
1.0 |
||
|
Occasionally/Always |
1.01 |
0.69–1.47 |
0.962 |
|
Condom use with primary partner: |
|||
|
Never |
1.0 |
||
|
Occasionally/Always |
0.75 |
0.38–1.48 |
0.406 |
|
Self-reported STI (syphilis, gonorrhea, chlamydia, genital herpes): |
|||
|
No |
1.0 |
||
|
Yes |
0.82 |
0.39–1.74 |
0.613 |
|
Disease serostatus: |
|||
|
HIV+ |
0.54 |
0.33–0.87 |
0.012 |
|
HCV+ |
0.10 |
0.02–0.50 |
0.005 |
|
Ever been tested for HIV: |
|||
|
No |
1.0 |
||
|
Yes |
1.11 |
0.56–2.17 |
0.766 |
|
Ever received drug treatment: |
|||
|
No |
1.0 |
||
|
Yes |
1.16 |
0.71–1.89 |
0.548 |
|
Ever been in prison: |
|||
|
No |
1.0 |
||
|
Yes |
1.11 |
0.67–1.86 |
0.680 |
|
|
|||
|
1Reference group SEP users. 2 Adjusted for age, gender, employment status, duration of injection career and intensity of injecting per day. |
|||
|
Vorobjov et al. Harm Reduction Journal 2009 6:3 doi:10.1186/1477-7517-6-3 |
|||